Trials / Completed
CompletedNCT00796913
Remission Induction and Sustenance in Graves' Disease 2
Prospective Randomized Study of Therapy Withdrawal vs Continued Low Dose Medical Therapy in Patients With Graves' Disease Entering Remission During ATD Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 139 (actual)
- Sponsor
- Aalborg University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ATD therapy for Graves' disease is one of the commonly used options for therapy of the hyperthyroidism. The investigators study how to optimally keep patients in remission.
Detailed description
A detailed description of patients entering the initial observational phase of the study (RISG1) has been published: Laurberg P, Nygaard B, Andersen S, Carlé A, Karmisholt J, Krejbjerg A, Pedersen IB, Andersen SL. Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves' Disease Study. J Thyroid Res. 2014;2014:165487. doi: 10.1155/2014/165487.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Stop medication | Stop medication Stop medication + se supplement |
Timeline
- Start date
- 2008-01-07
- Primary completion
- 2015-05-15
- Completion
- 2015-05-15
- First posted
- 2008-11-24
- Last updated
- 2019-01-10
Source: ClinicalTrials.gov record NCT00796913. Inclusion in this directory is not an endorsement.